Biohaven lines up rhinosinusitis patients for trial of its migraine med Nurtec ODT kdunleavy Tue, 02/22/2022 – 11:27 More: Biohaven lines up rhinosinusitis patients for trial of its migraine med Nurtec ODT Source: fierce
read moreMarch-in campaign on Pfizer’s prostate cancer med Xtandi gets congressional backing. Will it matter? fkansteiner Tue, 02/22/2022 – 10:38 More: March-in campaign on Pfizer's prostate cancer med Xtandi gets congressional backing. Will it matter? Source: fierce
read moreNovartis’ Leqvio to reap $2.5B by 2027 thanks to convenience edge over Amgen, Sanofi rivals: analyst kdunleavy Tue, 02/22/2022 – 09:47 More: Novartis' Leqvio to reap .5B by 2027 thanks to convenience edge over Amgen, Sanofi rivals: analyst Source: fierce
read moreJ&J to shutter Pennsylvania OTC manufacturing plant by 2023, report jkeenan Tue, 02/22/2022 – 09:36 More: J&J to shutter Pennsylvania OTC manufacturing plant by 2023, report Source: fierce
read moreGlaxoSmithKline unveils Haleon, the new brand name for its outgoing consumer health unit aliu Tue, 02/22/2022 – 09:25 More: GlaxoSmithKline unveils Haleon, the new brand name for its outgoing consumer health unit Source: fierce
read moreThe European Commission finds that Servier committed a breach of competition over blood pressure drug More: Victory Road: NHS successful in 11 year claim against Servier Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals